These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28285306)

  • 1. Extremely Low Prevalence of Amyloid Positron Emission Tomography Positivity in Parkinson's Disease without Dementia.
    Mashima K; Ito D; Kameyama M; Osada T; Tabuchi H; Nihei Y; Yoshizaki T; Noguchi E; Tanikawa M; Iizuka T; Date Y; Ogata Y; Nakahara T; Iwabuchi Y; Jinzaki M; Murakami K; Suzuki N
    Eur Neurol; 2017; 77(5-6):231-237. PubMed ID: 28285306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases.
    Lee SH; Cho H; Choi JY; Lee JH; Ryu YH; Lee MS; Lyoo CH
    Mov Disord; 2018 Feb; 33(2):262-272. PubMed ID: 29168583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review.
    Petrou M; Dwamena BA; Foerster BR; MacEachern MP; Bohnen NI; Müller ML; Albin RL; Frey KA
    Mov Disord; 2015 Jun; 30(7):928-35. PubMed ID: 25879534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography.
    Brooks DJ
    Mov Disord; 2009; 24 Suppl 2():S742-7. PubMed ID: 19877240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease.
    Winer JR; Maass A; Pressman P; Stiver J; Schonhaut DR; Baker SL; Kramer J; Rabinovici GD; Jagust WJ
    JAMA Neurol; 2018 Feb; 75(2):227-235. PubMed ID: 29228071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid PET Imaging in Lewy body disorders.
    Donaghy P; Thomas AJ; O'Brien JT
    Am J Geriatr Psychiatry; 2015 Jan; 23(1):23-37. PubMed ID: 23831180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging of dementia.
    Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
    Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1.
    Buongiorno M; Antonelli F; Compta Y; Fernandez Y; Pavia J; Lomeña F; Ríos J; Ramírez I; García JR; Soler M; Cámara A; Fernández M; Basora M; Salazar F; Sanchez-Etayo G; Valldeoriola F; Barrio JR; Marti MJ
    J Alzheimers Dis; 2017; 55(3):1261-1272. PubMed ID: 27814297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association of β-Amyloid with Cognition and Striatal Dopamine in Early, Non-Demented Parkinson's Disease.
    Oh YS; Yoo SW; Lyoo CH; Yoo JY; Yoon H; Ha S; Lee KS; Kim JS
    J Parkinsons Dis; 2021; 11(2):605-613. PubMed ID: 33646180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset.
    Fiorenzato E; Biundo R; Cecchin D; Frigo AC; Kim J; Weis L; Strafella AP; Antonini A
    J Alzheimers Dis; 2018; 66(1):229-237. PubMed ID: 30282359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study.
    Palermo G; Tommasini L; Aghakhanyan G; Frosini D; Giuntini M; Tognoni G; Bonuccelli U; Volterrani D; Ceravolo R
    J Alzheimers Dis; 2019; 70(2):597-609. PubMed ID: 31256138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.
    Edison P; Rowe CC; Rinne JO; Ng S; Ahmed I; Kemppainen N; Villemagne VL; O'Keefe G; Någren K; Chaudhury KR; Masters CL; Brooks DJ
    J Neurol Neurosurg Psychiatry; 2008 Dec; 79(12):1331-8. PubMed ID: 18653550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amyloid positron-emission-tomography with [
    Schönecker S; Prix C; Raiser T; Ackl N; Wlasich E; Stenglein-Krapf G; Mille E; Brendel M; Sabri O; Patt M; Barthel H; Bartenstein P; Levin J; Rominger A; Danek A
    Nervenarzt; 2017 Feb; 88(2):156-161. PubMed ID: 27913818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of amyloid-beta deposition in the cerebral cortex in Parkinson's disease.
    Mastaglia FL; Johnsen RD; Byrnes ML; Kakulas BA
    Mov Disord; 2003 Jan; 18(1):81-6. PubMed ID: 12518303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease.
    Melzer TR; Stark MR; Keenan RJ; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Grenfell S; Horne KL; Young BN; Pascoe MJ; Almuqbel MM; Wang J; Marsh SH; Miller DH; Dalrymple-Alford JC; Anderson TJ
    Front Neurol; 2019; 10():391. PubMed ID: 31105633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
    Jellinger KA; Korczyn AD
    BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
    Koeppe RA; Gilman S; Junck L; Wernette K; Frey KA
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S67-76. PubMed ID: 18632004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of beta-amyloid to dementia in Lewy body diseases: a 1-year follow-up study.
    Biundo R; Weis L; Fiorenzato E; Pistonesi F; Cagnin A; Bertoldo A; Anglani M; Cecchin D; Antonini A
    Brain Commun; 2021; 3(3):fcab180. PubMed ID: 34458730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia.
    Edison P; Ahmed I; Fan Z; Hinz R; Gelosa G; Ray Chaudhuri K; Walker Z; Turkheimer FE; Brooks DJ
    Neuropsychopharmacology; 2013 May; 38(6):938-49. PubMed ID: 23303049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.